PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25996834-3	2016	The aim of this study was to evaluate the in-vivo efficacy of the darunavir-SLN and demonstrate lymphatic transport as a contributing pathway in increasing the drug bioavailability.	Darunavir	66-75	sarcolipin	Rattus norvegicus	76-79	
25996834-8	2016	The detection of darunavir in the lymphatic fluid of the rats administered with darunavir-SLN further reinforced the conclusion of SLN being taken up by the lymphatic system.	Darunavir	17-26	sarcolipin	Rattus norvegicus	90-93	
25996834-8	2016	The detection of darunavir in the lymphatic fluid of the rats administered with darunavir-SLN further reinforced the conclusion of SLN being taken up by the lymphatic system.	Darunavir	17-26	sarcolipin	Rattus norvegicus	131-134	
25996834-8	2016	The detection of darunavir in the lymphatic fluid of the rats administered with darunavir-SLN further reinforced the conclusion of SLN being taken up by the lymphatic system.	Darunavir	80-89	sarcolipin	Rattus norvegicus	90-93	
25996834-8	2016	The detection of darunavir in the lymphatic fluid of the rats administered with darunavir-SLN further reinforced the conclusion of SLN being taken up by the lymphatic system.	Darunavir	80-89	sarcolipin	Rattus norvegicus	131-134